What's breaking now, across thousands of outlets.
Though positive, mid-stage study results erased about two-thirds of the biotech's market value this week. But Christopher Kroeger sees MapLight's drug as competitive based on the "totality of data."
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Rather than avoiding fresh produce, adopting a few sensible food safety practices can help you significantly reduce your risk of getting sick while continuing to enjoy the many health benefits and…
Women who received treatment for autoimmune diseases with CAR T cell therapy went on to have regular pregnancies and healthy babies.
A GWAS meta-analysis including 2.5 million individuals identified 26 genetic risk factors linked with fibromyalgia, identifying risk variants in 26 regions of the genome, many which are involved in…
Learn more about apoptosis' role in cancer and how finding the best animal model to test cancer drugs may lead us to cows.
At a contentious meeting with possible implications for other rare disease drugmakers, outside experts ultimately determined that Capricor didn't prove deramiocel's benefits in Duchenne-related…
The Chicxulub impact not only plunged Earth into an impact winter but also produced a dust blanket that later overheated the planet, according to new research from Purdue University and the University…
